Robert Park
Senior VP & CFO at Dolby Laboratories
Now moving on to our outlook for Q3 and the full year. Our outlook for Q3 is for revenue to be between $290,000,000 and $320,000,000 Within that, licensing revenue ranges from $265,000,000 to $295,000,000 Gross margins are expected to be approximately 88% on a non GAAP basis. Our outlook for non GAAP operating expenses is between $190,000,000 and 200,000,000 And with our effective tax rate for Q2 at about 20.5% on a non GAAP basis, non GAAP EPS is expected to come in between $0.62 and $0.77 per diluted share. For the full year, we have widened and lowered the range of revenue to be between $1,310,000,000 and $1,380,000,000 Our outlook for licensing revenue is to be between $1,210,000,000 and $1,280,000,000 We see non GAAP operating expenses between $760,000,000 and $775,000,000 and non GAAP earnings per share to be between $3.88 and $4.03 In closing, I'd like to remind you that Dolby has successfully navigated many technological and economic cycles. We have a resilient business model with a diversified global revenue base, deep partner relationships, high gross margins and a healthy balance sheet.